Neurology
Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
June 1, 2011 4:33 am | by Bio-Medicine.Org | News | CommentsNEW YORK, June 1, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017...
The Brain Stimulation Headset from Valkee Makes Light Work of Jet Lag, Job Stress and Winter Blues
June 1, 2011 12:34 am | by RealWire | News | CommentsThe Brain Stimulation Headset, Valkee (http://www.valkee.com), substitutes the mood-elevating effects of the sun, by channelling safe bright light directly to photosensitive regions of the brain through the ear canal. Valkee has been proven to increase energy, and can act as a...
MultiCell Technologies is Granted Stem Cell Patent
May 31, 2011 5:34 am | by Bio-Medicine.Org | News | CommentsWOONSOCKET, R.I., May 31, 2011 /- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET ) is pleased to announce the issuance of U.S. patent 7,935,528 by the United States Patent and Trademark Office (USPTO) relating to the isolation and use of human liver stem cells to treat liver...
Restorative Therapies, Inc., Today Announced a Rehabilitation Breakthrough, the RT600 Functional Electrical Stimulation (FES) Stepper
May 31, 2011 4:33 am | by Bio-Medicine.Org | News | CommentsBALTIMORE, May 31, 2011 /- Restorative Therapies, Inc., advances its new era in physical therapy systems for neurological injury and paralysis with FDA clearance of the world's first Functional Electrical Stimulation (FES) rehabilitation therapy system for stepping and standing. FES is a...
Northwestern Survey Finds FDA Predictability a Top Concern Among Medtech Firms; Europe Preferred for Product Approval
May 24, 2011 9:34 am | by Bio-Medicine.Org | News | CommentsWASHINGTON, May 24, 2011 /- Two-thirds of small medical device and diagnostic companies -- the drivers of innovation in the sector -- are obtaining clearance for new products in Europe first, suggesting delayed market entry in the U.S., according to a comprehensive industry-wide survey...
Images of a Hard-Hitting Disease
May 18, 2011 8:41 pm | by Massachusetts Institute of Technology | News | CommentsAdvanced imaging techniques could help diagnose the degenerative brain disease linked to repetitive head trauma.
Neuro Kinetics Releases Updated Version of Neuro-Otologic Control and Analysis Software
May 18, 2011 11:47 am | by Bio-Medicine.Org | News | CommentsPITTSBURGH, May 18, 2011 /- Neuro Kinetics, Inc. (NKI) ( www.neuro-kinetics.com ), manufacturers of noninvasive medical diagnostic equipment used worldwide for neuro-physiologic, neuro-otologic, vestibular and neurological testing, said today that it has released version 6.10 of its...
Celldex prices $31.5M stock offering
May 18, 2011 6:42 am | by Mass High Tech: The Journal of New England Technology | News | CommentsCelldex Therapeutics Inc., the Needham company developing a brain cancer vaccine, has priced a public offering of 10 million shares of its common stock at about $3.15 per share. The offering would raise $31.5 million, with Celldex taking in about $29.4 million in net proceeds.
Neurologix Announces First Quarter 2011 Financial Results
May 13, 2011 6:41 am | by Bio-Medicine.Org | News | CommentsFORT LEE, N.J., May 13, 2011 /- Neurologix, Inc. (OTCBB: NRGX), a biotechnology company engaged in the development of innovative gene therapies for disorders of the brain and central nervous system, today announced its financial results for the three months ended March 31, 2011. For the...
United Spinal Association Broadens Its Reach with Users First: Giving Voice to All Wheelchair Users
May 12, 2011 6:34 am | by Bio-Medicine.Org | News | CommentsNEW YORK, May 12, 2011 /PRNewswire-USNewswire/ -- United Spinal Association has announced the inclusion of Users First as a new program that advocates for improved access to seating and mobility equipment by empowering wheelchair users, clinicians, and providers. (Logo:...
Two Devices Treat Alzheimer's
May 11, 2011 8:34 pm | by Massachusetts Institute of Technology | News | CommentsCompanies hope that brain stimulation will work where drugs have failed.
Brain focused BeCaid joins incubator
May 11, 2011 8:35 am | by Mass High Tech: The Journal of New England Technology | News | CommentsYale University spinout BeCaid LLC, which is working on brain development programs that are tied to physical exercise, has become the latest member of Connecticut Innovations' CTech@Science Park incubator at Yale in New Haven, Conn.
Prexa releases details on $7M funding
May 11, 2011 7:38 am | by Mass High Tech: The Journal of New England Technology | News | CommentsPrexa Pharmaceuticals today revealed that Shire Pharmaceuticals was among the investors in Prexa's $7 million Series B financing, which was first reported in a filing with the U.S. Securities and Exchange Commission in late April.
Tourette Syndrome Association and Psyadon Pharmaceuticals to Collaborate on a Drug Trial for Tourette Syndrome Treatment
May 11, 2011 3:34 am | by Bio-Medicine.Org | News | CommentsBAYSIDE, N.Y. and GERMANTOWN, Md., May 11, 2011 /PRNewswire-USNewswire/ -- The national Tourette Syndrome Association (TSA) and Psyadon Pharmaceuticals Inc. are pleased to announce their collaboration on a clinical trial to determine the potential efficacy of a novel drug, ecopipam, for...
Adeona to Host First Quarter 2011 Investor Conference Call
May 10, 2011 11:36 am | by Bio-Medicine.Org | News | CommentsANN ARBOR, Mich., May 10, 2011 /- Adeona Pharmaceuticals, Inc. (AMEX: AEN ), a developer of innovative medicines for serious central nervous system diseases, announced today that it will hold its 1st quarter 2011 investor conference call on Tuesday, May 17, 2011, at 1:00pm EDT. James S....
83 Cases of Autism Associated with Childhood Vaccine Injury Compensated in Federal Vaccine Court
May 10, 2011 9:33 am | by Bio-Medicine.Org | News | CommentsWASHINGTON, May 10, 2011 /PRNewswire-USNewswire/ -- The following is being released by SafeMinds ( www.SafeMinds.org ): For over 20 years, the federal government has publicly denied a vaccine-autism link, while at the same time its Vaccine Injury Compensation Program (VICP) has been...
First-ever Gamma Knife in Paris Offers New Treatment Options for Patients With Cancer and Other Brain Disorders
May 10, 2011 6:34 am | by Bio-Medicine.Org | News | CommentsPARIS, May 10, 2011 /- Groupe Hospitalier Pitie Salpetriere, a world-renowned teaching hospital, and among Europe's largest medical centers has continued its long tradition of excellence in neurosciences and its expertise in radiation therapy with the acquisition of Leksell Gamma...
Bioness Inc. Receives FDA Clearance of Its NESS L300 Plus System
May 10, 2011 6:33 am | by Bio-Medicine.Org | News | CommentsVALENCIA, Calif., May 10, 2011 /- Bioness Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its NESS L300® Plus System. The device combines the Company's NESS L300® Foot Drop System with a thigh stimulation cuff, to...
Avanir Pharmaceuticals Announces Appointment of Elona Kogan, Esq. as Vice President of Legal Affairs
May 9, 2011 5:34 am | by Bio-Medicine.Org | News | CommentsALISO VIEJO, Calif., May 9, 2011 /- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) today announced the appointment of Elona Kogan, Esq. to the position of vice president of legal affairs. "At this time of growth and transition to a commercial stage biopharmaceutical company, Elona's legal,...
Lexicon Pharmaceuticals Announces Webcast of 2011 Annual R & D Day
May 9, 2011 4:32 am | by Bio-Medicine.Org | News | CommentsTHE WOODLANDS, Texas, May 9, 2011 /- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ) announced today that it will hold its Annual R&D Day on Thursday, May 12, 2011 from 9:00 a.m. to 12:00 p.m. Eastern Time in New York, New York. Members of Lexicon's senior management team will...
FDA Grants Orphan Drug Designation for Mithridion's MCD-386CR to Treat Progressive Supranuclear Palsy
May 8, 2011 8:46 pm | by Bio-Medicine.Org | News | CommentsMADISON, Wis., May 9, 2011 /- Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System (CNS) disorders, announces that the U.S. Food and Drug Administration (FDA) has awarded Orphan Drug designation for MCD-386CR, its lead drug...
InVivo Therapeutics, Miami Project to co-develop spinal cord injury treatments
May 4, 2011 8:41 am | by Mass High Tech: The Journal of New England Technology | News | CommentsInVivo Therapeutics Holdings Corp. of Cambridge and The University of Miami Miller School of Medicine's Miami Project to Cure Paralysis said today they have a strategic research collaboration to develop novel treatments for spinal cord injuries by combining their therapeutic approaches.
Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10
May 4, 2011 5:38 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO, May 4, 2011 /- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) today announced it will report first quarter 2011 financial results after the NASDAQ Global Select Market closes on Tuesday, May 10, 2011. That same afternoon, Jack Lief, Arena's President and Chief Executive Officer,...
Prexa names Graham, Reines to executive staff
May 2, 2011 8:34 am | by Mass High Tech: The Journal of New England Technology | News | CommentsPrexa Pharmaceuticals Inc., a Boston biotech focused on developments to treat central nervous system disorders, has appointed Evelyn Graham as chief operating officer and Scott Reines as chief medical officer.
Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film
May 2, 2011 8:34 am | by Bio-Medicine.Org | News | CommentsJERSEY CITY, N.J., May 2, 2011 /- Aoxing Pharmaceutical (NYSE Amex: AXN ) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products, announced that its operating subsidiary in China,...
